Delivery Order SPE2DB25D3017-SPE2DB25FVKFW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,266.38 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,011.74 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at approximately $24,925 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) under a firm fixed-price contract. The award was made on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical delivery order....
- The Defense Logistics Agency awarded a delivery order valued at $15,325.27 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on May 6, 2025, with an ultimate completion date of May 7, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $28,354.52 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $22,550.03 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) under a firm fixed price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this procurement action. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $39,189 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) under a firm fixed price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, with no set-aside designation applied. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,992.61 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $12,336.96 to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count packaging) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and represents a direct procurement of a brand-name pharmaceutical product for federal medical supply needs. The work will be performed at AmerisourceBergen's...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKFWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $66,325.99 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count packages) under a firm fixed-price contract. The award was issued on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a non-competitive delivery order. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that enables global pharmaceutical support across the defense healthcare system. Entresto, a brand-name pharmaceutical for heart failure treatment, exemplifies the scope of medications the contractor supplies to support military and veteran healthcare programs. The competitive award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements and its strategic role in the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.3k | 8/15/25 |